Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline.

Neuropsychiatr Dis Treat · 2018 · PMC6165742 · PMID 30310285

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

narrowly missed statistical significancep =0.051so close (0.05 < p ≤ 0.1)

49 Duloxetine was superior compared with placebo in improving functioning in one trial but not in the other one, although it narrowly missed statistical significance in the latter ( p =0.051).

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.